Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2026-04-09
Summary
The purpose of this study is to study the genetic profile of head and neck tumors and their relationship to treatment response and outcome
Conditions
- Head and Neck Neoplasms
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH -
National Institute of Dental and Craniofacial Research (NIDCR)
collaborator NIH -
National Cancer Institute (NCI)
collaborator NIH -
Montefiore Medical Center
lead OTHER
Principal Investigators
-
Richard V Smith, MD · Montefiore Medical Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-10-01
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- United States
Study Locations
More Related Trials
-
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)
NCT00341146 ·Status: COMPLETED
-
DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer
NCT00898664 ·Status: COMPLETED
-
Biomarkers in Patients With Head and Neck Cancer
NCT01466257 ·Status: COMPLETED
-
Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
NCT01109420 ·Status: RECRUITING
-
Study of Proteins in Head and Neck Cancer Cells
NCT00896948 ·Status: COMPLETED
-
Epigenetic Changes in Head and Neck Cancer
NCT04260074 ·Status: COMPLETED
-
Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
NCT01424878 ·Status: COMPLETED
-
Assessment of Early Genetic Changes in Smokers
NCT00200408 ·Status: TERMINATED
-
Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy
NCT00898430 ·Status: TERMINATED
-
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
NCT06744296 ·Status: RECRUITING
-
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
NCT01553175 ·Status: COMPLETED
-
Newer Therapeutic Targets in Head and Neck Cancers
NCT05382585 ·Status: RECRUITING
-
Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT00898742 ·Status: TERMINATED
-
Biospecimen Procurement for Head and Neck Disorders
NCT03429036 ·Status: RECRUITING
-
Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx
NCT00899340 ·Status: COMPLETED
-
Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer
NCT00482872 ·Status: COMPLETED
-
Genomic Predictors of Papillary Microcarcinoma Disease Progression
NCT02363595 ·Status: RECRUITING
-
Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers
NCT00580203 ·Status: COMPLETED
-
Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer
NCT02671045 ·Status: TERMINATED
-
Liquid Biopsy in Head and Neck Cancer
NCT03926468 ·Status: UNKNOWN
-
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT04099290 ·Status: RECRUITING
-
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
NCT01487733 ·Status: COMPLETED
-
International Cancer of the Head and Neck, Genetics and Environment (InterCHANGE) Study
NCT01972802 ·Status: UNKNOWN
-
Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma
NCT01365962 ·Status: COMPLETED
-
Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity
NCT05791149 ·Status: RECRUITING ·Phase: NA